Lai Wan-Yu, Wei Chang-Ching, Lin Chien-Heng, Hang Liang-Wen, Shih Ying-Hsiu, Huang Fen-Wei, Yen Hung-Rong
Department of Chinese Medicine, China Medical University Hospital, Taichung, Taiwan.
School of Chinese Medicine, College of Chinese Medicine, China Medical University, Taichung, Taiwan.
J Tradit Complement Med. 2023 Aug 7;14(1):109-120. doi: 10.1016/j.jtcme.2023.08.002. eCollection 2024 Jan.
Obstructive sleep apnea (OSA) is a chronic disease that affects 1%-6% of children. Our study aims to explore the effectiveness and clinical characteristics of integrative Traditional Chinese Medicine (ITCM) for pediatric OSA.
In this retrospective cohort study, we assessed differences of polysomnography (PSG) parameters and clinical characteristics between 2009 and 2020. Children <12 years old diagnosed with OSA (n = 508) were included and were categorized into ITCM cohort, western medicine (WM) cohort ,and surgery cohort. Outcomes were apnea-hypopnea index (AHI), respiratory disturbance index (RDI), and body mass index (BMI).
There were 56 (11%), 324 (63.8%), and 128 (25.2%) patients in the ITCM, WM, and surgery cohorts. Among 17, 26, and 33 patients in the ITCM, WM, and surgery cohorts underwent follow-up PSG studies, respectively. In the ITCM follow-up cohort, AHI were significantly reduced (9.59 to 5.71, p < 0.05). BMI significantly increased in the WM follow-up cohort (19.46 to 20.50, p < 0.05) and the surgery follow-up cohort (18.04 to 18.85, p < 0.01). Comparing ITCM to WM cohort, a significant difference was found between the changes in RDI (ITCM: -6.78, WM: 0.51, p < 0.05) after treatment. Among ITCM follow-up cohort, the most prescribed TCM formula was Forsythia and Laminaria Combination. The most prescribed TCM herb was Ephedrae Herba.
ITCM therapy can significantly reduce RDI and control BMI. We identified potential TCM treatments for pediatric OSA. Further study of the pharmacological mechanisms and clinical efficacy is warranted.
阻塞性睡眠呼吸暂停(OSA)是一种影响1% - 6%儿童的慢性疾病。本研究旨在探讨中医综合疗法(ITCM)治疗小儿OSA的有效性及临床特征。
在这项回顾性队列研究中,我们评估了2009年至2020年间多导睡眠图(PSG)参数及临床特征的差异。纳入12岁以下诊断为OSA的儿童(n = 508),并将其分为中医综合治疗组、西医治疗组和手术治疗组。观察指标为呼吸暂停低通气指数(AHI)、呼吸紊乱指数(RDI)和体重指数(BMI)。
中医综合治疗组、西医治疗组和手术治疗组分别有56例(11%)、324例(63.8%)和128例(25.2%)患者。中医综合治疗组、西医治疗组和手术治疗组分别有17例、26例和33例患者接受了PSG随访研究。在中医综合治疗随访组中,AHI显著降低(从9.59降至5.71,p < 0.05)。西医治疗随访组(从19.46升至20.50,p < 0.05)和手术治疗随访组(从18.04升至18.85,p < 0.01)的BMI显著增加。比较中医综合治疗组和西医治疗组,治疗后RDI变化有显著差异(中医综合治疗组:-6.78,西医治疗组:0.51,p < 0.05)。在中医综合治疗随访组中,最常用的中药方剂是连翘海藻方。最常用的中药是麻黄。
中医综合疗法可显著降低RDI并控制BMI。我们确定了小儿OSA的潜在中医治疗方法。有必要进一步研究其药理机制和临床疗效。